期刊文献+

腺病毒介导的野生型p53基因对人肺腺癌细胞放疗敏感性的影响 被引量:1

Effect of Adenovirus-mediated wild-type p53 gene transfection on the growth and radiosensitivity of human lung adenocarcinoma cells
下载PDF
导出
摘要 目的:研究腺病毒介导的野生型p53基因(Ad-p53)对人肺腺癌细胞生长及放疗敏感性的影响。方法:将重组的含野生型p53基因的腺病毒导入A549细胞,通过免疫细胞化学方法检测p53基因的表达。A549细胞分为4组:对照组、转染组、放疗组、转染联合放疗组。用四甲基偶氮唑盐比色法(MTT法)和流式细胞仪检测p53基因以及联合放射治疗(2,4,6 Gy)对A549细胞生长抑制及凋亡的影响。结果:通过免疫细胞化学方法证实了p53基因在A549细胞中的表达。MTT法检测发现p53基因对A549细胞的生长抑制率为(50.60±5.69)%。当放射剂量为2,4,6 Gy时,A549细胞的生长抑制率分别为(16.06±4.35)%、(16.39±1.67)%、(17.73±4.68)%。当p53基因与放疗(2,4,6 Gy)联合作用时,抑制率分别为(80.60±5.35)%,(89.30±1.67)%、(90.30±2.01)%(P<0.01)。p53基因转染所产生的A549细胞凋亡率为(10.38±1.68)%。放疗(2,4,6 Gy)引起的细胞凋亡率分别为(3.98±0.72)%、(4.84±0.60)%、(5.40±0.70)%。当p53基因与放疗(2,4,6 Gy)联合作用时,凋亡率分别为(17.80±1.30)%、(19.03±0.54)%、(21.34±2.51)%(P<0.01)。结论:野生型p53基因与放疗对人肺腺癌细胞生长有协同抑制作用。 Objective: To evaluate the effects of wild-type p53 gene on the growth and radiosensitivity of human lung adenocarcinoma ceils. Methods: Recombinant adenovirus carrying wild-type p53 gene (Ad-p53 ) was transferred into human lung adenocarcinoma cell A549, and p53 protein expression was detected by immunocytochemistry. A549 cell was divided into 4 groups : control group, transfection group, radiation group and combined treatment group. The cell growth inhibition and apoptosisin were assessed by MTT and flowcytometry. Results : The transfection of p53 gene into A549 ceils was confirmed by immunocytochemistry. MTT showed that the inhibition rate (IR) on the growth of A549 ceils transferred into by Ad-p53 gene was (50.60 ± 5.69 ) %. The IR of radiation (2,4,6 Gy ) on A549 cells was respectively ( 16.06 ± 4.35) %, ( 16.39 ± 1.67 ) %, ( 17.73 ± 4.68) %. When combined treatment of wild-type p53 gene transfection and radiation was used, their IR was (80.60 ±5.35)%, (89.30 ± 1.67)%, (90.30 ±2.01 )%, significantly increased (P 〈 0.05). The apoptotic rate(AR) of A549 ceils induced by p53 gene transfection was ( 10.38 ± 1.68 ) %. Their AR by radiation ( 2,4,6 Gy) was ( 3.98 ± 0.72 ) %, (4.84 ± 0.60) %, (5.40 ±0.70)%. The apoptotic rate was also significantly increased to ( 17.80 ± 1.30)%, ( 19.03 ± 0.54 ) % , ( 21.3 4 ± 2.51 ) % respectively aftercombined treatment of p53 and radiation ( 2,4,6 Gy ) with different doses( P 〈 0.05 ). Conclusion: Wild-type p53 gene and radiation could result in synergistic inhibition effect on the growth of human lung adenocarcinoma cells and increase radiosensitivity.
出处 《江苏大学学报(医学版)》 CAS 2006年第5期427-429,共3页 Journal of Jiangsu University:Medicine Edition
关键词 基因治疗 P53基因 肺腺癌 放射治疗 genetherapy p53 gene human lung adenocarcinoma radiationtherapy
  • 相关文献

参考文献9

  • 1邓红彬,张幸平.p53基因突变与肺癌放射治疗敏感性的研究进展[J].国外医学(临床生物化学与检验学分册),2004,25(3):243-245. 被引量:1
  • 2Irie K, Irie K, Ishida H, et al. Clinicopathological study on primary lung cancer-immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis [ J ]. Rinsho Byori, 1996 ,LM.( 1 ) :32 - 41.
  • 3Schwartz JL, Rasey J, Wiens L, et al. Functional inactivation of p53 by HPV-E6 transformation is associated with a reduced expression of radiation-induced potentially lethal damage[ J ]. Int J Radiat, 1999,75 ( 3 ) : 285 -291.
  • 4Ali J, Jacob F, Claudia L,et al. ATM and cell cycledependent regulation of ATR in Response to DNA double-strand breaks [ J ]. Nature Cell Biology, 2006,8 ( 1 ) :37 - 45.
  • 5Yvonne L, Woods, Dimitris P,et al. P14-Arf promotes small ubiquitin-like modifier conju- gation of werners helicase [ J ]. J Biological Chemistry, 2004, 279 ( 11 ) :50157- 50166.
  • 6Stephen G, Swisher B, Jack A, et al. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 ( INGN 201 ) and radiation therapy [ J ]. Clinical Cancer Research,2003,9( 1 ) :93 - 101.
  • 7Kawabe S, Munshi A, Zumstein L,et al. Adenovirusmediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts [ J ]. Int J Radiat Biol, 2001,77 (2) : 185 -194.
  • 8Bennett WP , Hussain SP , Vahakangas KH , et al. Molecular epidemiology of human cancer risk: gene- environment interactions and p53 mutation spectrum in human lung cancer[J]. J Pathol,1999,18(7) :8 -18.
  • 9Takahashi T, Carbone D,Takahashi T, et al. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions[ J]. Cancer Res, 1992,5 (2) :340-343.

二级参考文献13

  • 1Yuan A,Yu CJ,Luh KT,et al.Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.J Clin Oncol,2002,20(4):900-910.
  • 2Gu CD,Osaki T,Oyama T,et al.Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer:impact on recurrence and Survival.Ann Surg,2002,235(1):133-139.
  • 3Maruyama R,Sugio K,Fukuyama Y,et al.Evaluation of p53 alterations in occult lymph node metastases.J Surg Oncol,2000,73(3):143-147.
  • 4Moldvay J,Scheid P,Wild P,et al.Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.Clin Cancer Res,2000,6(3):1125-1134.
  • 5Matsuzoe D,Hideshima T,Kimura A,et al.p53 mutations predict non-small cell lung carcinoma response to radiotherapy.Cancer Lett,1999,135(2):189-194.
  • 6Safran H,King T,Choy H,et al.p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma.Cancer,1996,78(6):1203-1210.
  • 7King TC,Estalilla OC,Safran H.Role of p53 and p16 gene alterations in determining response to concurrent paclitaxel and radiation in solid tumor.Semin Radiat Oncol,1999,9(2 Suppl 1):4-11.
  • 8Baker SJ,Markowitz S,Fearon ER,et al.Suppression of human colorectal carcinoma cell growth by wild-type p53.Science,1990,249(4971):912-915.
  • 9Roth JA,Grammer SF,Swisher SG,et al.Gene replacement strategies for treating non-small cell lung cancer.Semin Radiat Oncol,2000,10(4):333-342.
  • 10Dworakowska D,Gozdz S,Jassem E,et al.Prognostic relevance of proliferating cell nuclear antigen and p53 expression in non-small cell lung cancer.Lung Cancer,2002,35(1):35-41.

同被引文献8

  • 1郑莉,任加强,陈琦,张慧萍,朱虹光.HER2/neu过表达通过PI3K/Akt通路对乳腺癌细胞MCF7中p53基因表达及细胞生长和放疗敏感性的影响[J].中华肿瘤杂志,2004,26(10):594-597. 被引量:19
  • 2T L Yuan ,L C Cantley. PI3K pathway alterations in cancer: variations on a theme [ J ]. Oneogene ( 2008 ) 27,5497 - 5510.
  • 3Lee CM, Fuhrman CB, Planelles V. Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines[ J]. Clin Cancer Res ,2006,12( 1 ) :250 - 256.
  • 4Xu J, Gao M, Fan S. Effect of Akt inhibition on scatter factor-regulated gene Expression in DU-145 human prostate cancer cells[ J]. Oncogene,2007,26 (20) :2925 - 2938.
  • 5Junttila, Robert W. Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941 [ J ]. Cancer Cell, 2009, 15 ( 5 ) : 429 - 440.
  • 6Gottlieb TM, Yaya Y. Cross-talk possible implication torthe regulation of apoptosis[ J]. Oneogene,2001,21:1299 - 1303.
  • 7Howells LM, Hudson EA, Manson MM. Inhibition of phosphatiaylino sitol 3-kinase/protein kinase B signaling is not sufficient to account for inable-3-carbinol-induced apoptosis in some breast and prostate tumor cell[ J]. Clin cancer Res ,2005,11 (23) :8521 - 8527.
  • 8黄燕萍,金克炜,高倩,李宝刚.云南个旧和宣威地区肺癌p53突变检测研究[J].华西医科大学学报,2001,32(3):361-364. 被引量:4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部